Phio Pharmaceuticals Corp. also files under RXII; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Plott Ronald Todd | Director | Buy(P) | 15K | $1.14 | $17K |
| Aug 18, 2026 | Bitterman Robert J | Chairman, Pres. & CEO, Director | Buy(P) | 10K | $1.06 | $11K |
| Jun 26, 2026 | Bitterman Robert J | Chairman, Pres. & CEO, Director | Buy(P) | 10K | $0.99 | $10K |
| Feb 5, 2026 | Bitterman Robert J | Chairman, Pres. & CEO, Director | Grant(A) | 120K | — | $0 |
| Feb 5, 2026 | Carson Lisa Cabott | Chief Financial Officer | Grant(A) | 47K | — | $0 |
| Feb 5, 2026 | Deming David H | Director | Grant(A) | 24K | — | $0 |
| Feb 5, 2026 | Lockshin Curtis | Director | Grant(A) | 17K | — | $0 |
| Feb 5, 2026 | Bradford Patricia A | Director | Grant(A) | 19K | — | $0 |
| Feb 5, 2026 | Freeman Jonathan E | Director | Grant(A) | 17K | — | $0 |
| Dec 31, 2025 | Bitterman Robert J | Chairman, Pres. & CEO, Director | Buy(P) | 5K | $1.03 | $5K |
| Dec 23, 2025 | Bitterman Robert J | Chairman, Pres. & CEO, Director | Buy(P) | 5K | $1.02 | $5K |
| Nov 21, 2025 | Bitterman Robert J | Chairman, Pres. & CEO, Director | Buy(P) | 5K | $1.14 | $6K |
| Nov 18, 2025 | Bitterman Robert J | Chairman, Pres. & CEO, Director | Buy(P) | 5K | $1.27 | $6K |
| Sep 11, 2025 | Freeman Jonathan E | Director | Grant(A) | 15K | — | $0 |
| Sep 11, 2025 | Carson Lisa Cabott | VP, Finance and Administration | Grant(A) | 47K | — | $0 |
| Sep 11, 2025 | Lockshin Curtis | Director | Grant(A) | 16K | — | $0 |
| Sep 11, 2025 | Bradford Patricia A | Director | Grant(A) | 19K | — | $0 |
| Sep 11, 2025 | Bitterman Robert J | Chairman, Pres. & CEO, Director | Grant(A) | 250K | — | $0 |
| Sep 11, 2025 | Bitterman Robert J | Chairman, Pres. & CEO, Director | Tax withholding(F) | 4K | $2.32 | $10K |
| Sep 11, 2025 | Ferrara Robert L | Director | Grant(A) | 23K | — | $0 |
| Sep 11, 2025 | Deming David H | Director | Grant(A) | 14K | — | $0 |
| Jun 10, 2025 | Bitterman Robert J | Chairman, Pres & CEO, Director | Buy(P) | 2K | $2.42 | $5K |
| Jun 10, 2025 | Ferrara Robert L | Director | Buy(P) | 3K | $2.42 | $6K |
| Jun 9, 2025 | Bitterman Robert J | Chairman, Pres & CEO, Director | Buy(P) | 2K | $2.75 | $4K |
| May 22, 2025 | Bitterman Robert J | Chairman, Pres & CEO, Director | Buy(P) | 1K | $1.78 | $2K |
| May 21, 2025 | Bitterman Robert J | Chairman, Pres & CEO, Director | Buy(P) | 3K | $1.77 | $5K |
| May 20, 2025 | Ferrara Robert L | Director | Buy(P) | 3K | $1.82 | $5K |
| Sep 11, 2024 | Infarinato Robert M. | VP, CFO | Grant(A) | 3K | — | $0 |
| Sep 11, 2024 | Freeman Jonathan E | Director | Grant(A) | 1K | — | $0 |
| Sep 11, 2024 | Bitterman Robert J | Chairman, Pres & CEO, Director | Grant(A) | 16K | — | $0 |
| Sep 11, 2024 | Lockshin Curtis | Director | Grant(A) | 2K | — | $0 |
| Sep 11, 2024 | Ferrara Robert L | Director | Grant(A) | 10K | — | $0 |
| Sep 11, 2024 | Bradford Patricia A | Director | Grant(A) | 8K | — | $0 |
| Aug 13, 2024 | Infarinato Robert M. | VP, Chief Financial Officer | Grant(A) | 8K | — | $0 |
| Jun 7, 2024 | Bitterman Robert J | President & CEO, Director | Buy(P) | 1K | $0.74 | $740 |
| Jun 6, 2024 | Bitterman Robert J | President & CEO, Director | Buy(P) | 1K | $0.75 | $750 |
| Mar 1, 2024 | Kontulis Caitlin | Secretary & VP Finance & Admin | Tax withholding(F) | 335 | $0.96 | $322 |
| Feb 26, 2024 | Bitterman Robert J | President & CEO, Director | Buy(P) | 3K | $0.91 | $2K |
| Feb 20, 2024 | Bitterman Robert J | President & CEO, Director | Tax withholding(F) | 2K | $0.76 | $1K |
| Feb 17, 2024 | Kontulis Caitlin | Secretary & VP Finance & Admin | Tax withholding(F) | 523 | $0.66 | $345 |
| Feb 15, 2024 | Kontulis Caitlin | Secretary & VP Finance & Admin | Tax withholding(F) | 658 | $0.65 | $428 |
| Oct 1, 2023 | Bitterman Robert J | President & CEO, Director | Tax withholding(F) | 917 | $1.51 | $1K |
| Jul 1, 2023 | Bitterman Robert J | President & CEO, Director | Buy(P) | 1K | $2.84 | $3K |
| Jun 30, 2023 | Bitterman Robert J | President & CEO, Director | Buy(P) | 1K | $2.88 | $3K |
| Jun 14, 2023 | Ferrara Robert L | Director | Buy(P) | 2K | $3.10 | $6K |
| Mar 1, 2023 | Kontulis Caitlin | Secretary & VP Finance & Admin | Tax withholding(F) | 335 | $5.49 | $2K |
| Feb 20, 2023 | Bitterman Robert J | President & CEO, Director | Grant(A) | 11K | — | $0 |
| Feb 17, 2023 | Kontulis Caitlin | Secretary & VP Finance & Admin | Grant(A) | 5K | — | $0 |
| Feb 17, 2023 | Lockshin Curtis | Director | Grant(A) | 2K | — | $0 |
| Feb 17, 2023 | Freeman Jonathan E | Director | Grant(A) | 2K | — | $0 |
| Feb 17, 2023 | Ferrara Robert L | Director | Grant(A) | 2K | — | $0 |
| Feb 17, 2023 | Cauwenbergh Geert | Director | Grant(A) | 2K | — | $0 |
| Feb 17, 2023 | Bradford Patricia A | Director | Grant(A) | 2K | — | $0 |
| Feb 15, 2023 | Kontulis Caitlin | Secretary & VP Finance & Admin | Tax withholding(F) | 657 | $5.20 | $3K |
| Dec 14, 2022 | Bitterman Robert J | Interim Executive Chairman, Director | Buy(P) | 2K | $0.39 | $780 |
| Dec 7, 2022 | Bitterman Robert J | Interim Executive Chairman, Director | Buy(P) | 2K | $0.39 | $780 |
| Dec 5, 2022 | Bitterman Robert J | Interim Executive Chairman, Director | Buy(P) | 2K | $0.43 | $860 |
| Dec 2, 2022 | Ferrara Robert L | Director | Buy(P) | 5K | $0.41 | $2K |
| Nov 29, 2022 | Bitterman Robert J | Interim Executive Chairman, Director | Buy(P) | 215 | $0.40 | $86 |
| Nov 25, 2022 | Bitterman Robert J | Interim Executive Chairman, Director | Buy(P) | 3K | $0.42 | $1K |
| Nov 23, 2022 | Ferrara Robert L | Director | Buy(P) | 2K | $0.41 | $820 |
| Nov 16, 2022 | Bitterman Robert J | Interim Executive Chairman, Director | Buy(P) | 1 | $1,750.00as filed | — |
| Oct 1, 2022 | Bitterman Robert J | Director | Grant(A) | 40K | — | $0 |
| Aug 9, 2022 | Bradford Patricia A | Director | Grant(A) | 20K | — | $0 |
| Mar 1, 2022 | Kontulis Caitlin | Secretary & VP Finance & Admin | Tax withholding(F) | 4K | $0.82 | $3K |
| Mar 1, 2022 | Dispersyn Gerrit | President & CEO, Director | Tax withholding(F) | 9K | $0.82 | $7K |
| Feb 15, 2022 | Cauwenbergh Geert | Director | Grant(A) | 10K | — | $0 |
| Feb 15, 2022 | Dorman H. Paul | Director | Grant(A) | 10K | — | $0 |
| Feb 15, 2022 | Dispersyn Gerrit | President & CEO, Director | Grant(A) | 126K | — | $0 |
| Feb 15, 2022 | Bitterman Robert J | Director | Grant(A) | 10K | — | $0 |
| Feb 15, 2022 | Lockshin Curtis | Director | Grant(A) | 10K | — | $0 |
| Feb 15, 2022 | Kontulis Caitlin | Secretary & VP Finance & Admin | Grant(A) | 68K | — | $0 |
| Feb 15, 2022 | Freeman Jonathan E | Director | Grant(A) | 10K | — | $0 |
| Feb 15, 2022 | Ferrara Robert L | Director | Grant(A) | 10K | — | $0 |
| Aug 16, 2021 | Dispersyn Gerrit | President & CEO, Director | Buy(P) | 6K | $1.63 | $10K |
| Mar 4, 2021 | Dispersyn Gerrit | President & CEO, Director | Buy(P) | 2K | $2.56 | $5K |
| Mar 3, 2021 | Ferrara Robert L | Director | Buy(P) | 682 | $3.15 | $2K |
| Mar 3, 2021 | Dispersyn Gerrit | President & CEO, Director | Buy(P) | 3K | $3.03 | $8K |
| Mar 1, 2021 | Cauwenbergh Geert | Director | Grant(A) | 10K | — | $0 |
| Mar 1, 2021 | Freeman Jonathan E | Director | Grant(A) | 10K | — | $0 |
| Mar 1, 2021 | Dispersyn Gerrit | President & CEO, Director | Grant(A) | 68K | — | $0 |
| Mar 1, 2021 | Dorman H. Paul | Director | Grant(A) | 10K | — | $0 |
| Mar 1, 2021 | Kontulis Caitlin | Secretary & VP Finance & Admin | Grant(A) | 35K | — | $0 |
| Mar 1, 2021 | Ferrara Robert L | Director | Grant(A) | 10K | — | $0 |
| Mar 1, 2021 | Lockshin Curtis | Director | Grant(A) | 10K | — | $0 |
| Mar 1, 2021 | Bitterman Robert J | Director | Grant(A) | 10K | — | $0 |
| Aug 19, 2020 | Dispersyn Gerrit | President & CEO | Buy(P) | 2K | $2.50 | $5K |
| Mar 1, 2020 | Dispersyn Gerrit | President & CEO | Tax withholding(F) | 673 | $2.93 | $2K |
| Nov 18, 2019 | Cauwenbergh Geert | Director | Grant(A) | 225K | $0.10 | $23K |
| Nov 18, 2019 | Bitterman Robert J | Director | Grant(A) | 300K | $0.10 | $30K |
| Nov 18, 2019 | Ferrara Robert L | Director | Grant(A) | 128K | $0.10 | $13K |
| Nov 18, 2019 | Dispersyn Gerrit | President & CEO | Grant(A) | 350K | $0.10 | $35K |
| Nov 18, 2019 | Kontulis Caitlin | Secretary & VP Finance & Admin | Grant(A) | 238K | $0.10 | $24K |
| Aug 1, 2019 | Cauwenbergh Geert | Director | Tax withholding(F) | 2K | $0.40 | $700 |
| Aug 1, 2019 | Dispersyn Gerrit | President & CEO | Tax withholding(F) | 1K | $0.40 | $494 |
| Aug 1, 2019 | Kontulis Caitlin | Secretary & VP Finance & Admin | Tax withholding(F) | 749 | $0.40 | $300 |
| Apr 22, 2019 | Barrett John A | Chief Development Officer | Grant(A) | 223K | — | $0 |
| Mar 1, 2019 | Dispersyn Gerrit | President & CEO | Grant(A) | 408K | — | $0 |
| Feb 28, 2019 | Cauwenbergh Geert | Chief Executive Officer, Director | Grant(A) | 152K | $0.38 | $58K |
| Feb 15, 2019 | Cauwenbergh Geert | Chief Executive Officer, Director | Grant(A) | 22K | $0.36 | $8K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Phio Pharmaceuticals Corp., SEC CIK 0001533040. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under PHIO and shows every filing by that issuer (also filed as RXII).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for PHIO